Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02115048
Title Clinical Study for the Treatment of Breast Cancer the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Translational Research in Oncology
Indications

Her2-receptor negative breast cancer

Therapies

Afatinib

Letrozole

Age Groups: adult
Covered Countries USA | ESP

Additional content available in CKB BOOST